| Metastasis in renal cell carcinoma: Biology and implications for therapy J Gong, MC Maia, N Dizman, A Govindarajan, SK Pal Asian journal of urology 3 (4), 286-292, 2016 | 151 | 2016 |
| Stool microbiome profiling of patients with metastatic renal cell carcinoma receiving anti–PD-1 immune checkpoint inhibitors NJ Salgia, PG Bergerot, MC Maia, N Dizman, JA Hsu, JD Gillece, ... European urology 78 (4), 498-502, 2020 | 133 | 2020 |
| A comprehensive review of immunotherapies in prostate cancer MC Maia, AR Hansen Critical reviews in oncology/hematology 113, 292-303, 2017 | 73 | 2017 |
| Association of circulating tumor DNA (ctDNA) detection in metastatic renal cell carcinoma (mRCC) with tumor burden MC Maia, PG Bergerot, N Dizman, JA Hsu, J Jones, RB Lanman, ... Kidney Cancer 1 (1), 65-70, 2017 | 44 | 2017 |
| Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers MC Maia, M Salgia, SK Pal Nature Reviews Urology 17 (5), 271-291, 2020 | 39 | 2020 |
| Systemic therapy for non–clear cell renal cell carcinoma T Zhang, J Gong, MC Maia, SK Pal American Society of Clinical Oncology Educational Book 37, 337-342, 2017 | 26 | 2017 |
| Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review MC Maia, A Hansen, C Alves, S Salah Critical reviews in oncology/hematology 135, 76-84, 2019 | 24 | 2019 |
| Relationship of tumor mutational burden (TMB) to immunotherapy response in metastatic renal cell carcinoma (mRCC). MC Maia, L Almeida, PG Bergerot, N Dizman, SK Pal Journal of Clinical Oncology 36 (6_suppl), 662-662, 2018 | 22 | 2018 |
| Assessment of treatment patterns for metastatic renal cell carcinoma in Brazil PG Bergerot, CD Bergerot, N Dizman, S Zequi, A Fay, Y Dara, MC Maia, ... Journal of global oncology 4, 1-8, 2017 | 22 | 2017 |
| Efficacy and safety of docetaxel in elderly patients with metastatic castration-resistant prostate cancer MC Maia, AAL Pereira, LV Lage, NM Fraile, VV Vaisberg, G Kudo, ... Journal of Global Oncology 4, 1-9, 2017 | 14 | 2017 |
| Association of microbiome and plasma cytokine dynamics to nivolumab response in metastatic renal cell carcinoma (mRCC). MC Maia, V Poroyko, H Won, L Almeida, PG Bergerot, N Dizman, J Hsu, ... Journal of Clinical Oncology 36 (6_suppl), 656-656, 2018 | 12 | 2018 |
| Consensus on the treatment and follow-up for metastatic castration-resistant prostate cancer: a report from the first global prostate cancer consensus conference for developing … FC Maluf, FMT Pereira, AG Silva, ALA Dettino, APG Cardoso, AS Sasse, ... JCO Global Oncology 7, 559-571, 2021 | 11 | 2021 |
| Cytoreductive nephrectomy for metastatic renal cell carcinoma: how to apply new evidence in clinical practice A Soares, MC Maia, F Vidigal, FS Marques Monteiro Oncology 98 (1), 1-9, 2020 | 11 | 2020 |
| Circulating tumor DNA in bladder cancer: novel applications and future directions MC Maia, P Grivas, N Agarwal, SK Pal European urology 73 (4), 541-542, 2018 | 9 | 2018 |
| Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer … A Soares, FSM Monteiro, FC Maluf, DA Bastos, DL Jardim, AD Sasse, ... Journal of cancer research and clinical oncology 146, 1829-1845, 2020 | 8 | 2020 |
| Current systemic therapies for metastatic renal cell carcinoma in older adults: A comprehensive review MC Maia, J Adashek, P Bergerot, L Almeida, SF Dos Santos, SK Pal Journal of geriatric oncology 9 (3), 265-274, 2018 | 6 | 2018 |
| Presence of antibiotic-resistant Enterococcus faecalis in colostrum supplied to calves S Cunha, R Soares, M Maia, G Igrejas, F Silva, C Miranda, P Poeta Meeting of the The 1st International Electronic Conference on Antibiotics …, 2021 | 5 | 2021 |
| Phase 1b trial of cabozantinib in combination with atezolizumab in patients with locally advanced or metastatic urothelial carcinoma (UC) or renal cell carcinoma (RCC). MC Maia, N Agarwal, BA McGregor, UN Vaishampayan, TK Choueiri, ... Journal of Clinical Oncology 36 (5_suppl), TPS42-TPS42, 2018 | 5 | 2018 |
| A step towards predicting checkpoint inhibitor response in kidney cancer MC Maia, ES Yang, N Agarwal, SK Pal The Lancet Oncology 18 (8), 982-983, 2017 | 4 | 2017 |
| Therapeutic sequencing in metastatic renal cell carcinoma MC Maia, N Dizman, M Salgia, SK Pal Kidney Cancer 1 (1), 15-29, 2017 | 4 | 2017 |
